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LETTER
Motion sickness in migraine
and vestibular disorders
Motion sickness is a syndrome provoked by
sensory conﬂict that involves the vestibular
system with symptoms resembling those of
common neuro-otological disorders includ-
ing vestibular neuritis (VN) and vestibular
migraine (VM). By contrast, it is generally
believed that bilateral vestibular failure
(BVF) causes reduced motion sickness sus-
ceptibility. We investigate differences
between these conditions with a single
protocol using validated objective experi-
mental (off-vertical axis rotation, OVAR1)
and validated patient-centred measures of
motion sickness susceptibility.2
Five groups were studied:
1. Normal healthy controls (n=12; mean
age 51, SD 17.2; 4/12 women).
2. VN (history of acute vertigo without
neurological features or hearing loss;
none treated with steroids acutely;
positive head thrust test; spontaneous
unidirectional horizontal nystagmus;
acute caloric canal paresis >30%,
mean canal paresis repeated in chronic
phase after 6 weeks was 38% (SD 31);
n=12; disease duration range 10–
33 months; mean age 45, SD 15.3;
5/12 women).
3. BVF (absent caloric or rotational
responses; conﬁrmed in chronic phase;
n=8; mean age 51, SD 11.5; 3/8
women).
4. VM (recurrent episodic vestibular
symptoms in association with migraine
according to published criteria with no
vestibular test abnormalities3; n=12;
mean age 45, SD 15.3; 11/12 women).
5. Migraine without vestibular symptoms
(M; recurrent headaches meeting
International Headache Society (IHS)
2004 criteria; with/without aura but
with no signiﬁcant vestibular symp-
toms3; n=12; mean age 41, SD 13.6;
8/12 women.
Two groups of patient with migraine
were studied (one with vestibular symp-
toms, VM, and one without vestibular
symptoms, M) to determine whether the
presence of vestibular symptoms in the
setting of migraine inﬂuences motion sick-
ness susceptibility. The normal controls
and the migraine group were screened for
vestibular symptoms but did not undergo
formal vestibular testing.
Participants were seated in a motorised
chair (Neurokinetics Inc, Pittsburgh,
USA). The torso, legs, feet and head were
restrained. The chair took 60 s to reach a
constant velocity of 72°/s (0.2 Hz) on a
vertical axis in the light, then tilted over
20 s to an angle of 18° from earth vertical.
Velocity and tilt remained constant until
the chair was stopped, when it was
Figure 1 (A) Mean SR (y axis)
against time for all ﬁve groups (1=no
nausea, 2=initial symptoms but no
nausea, 3=mild nausea, 4=moderate
nausea (stop motion)). In the ﬁrst
frame on the left, time t=0 is at onset
of chair motion. For the purposes of
illustration, continuation values of
Sickness Rating=4 were inserted for
those who terminated at moderate
nausea before reaching the 20 min
motion exposure time cut-off (marked
as stop motion on the x axis) From the
point of stop motion, time periods on
the x axis are denoting length of
recovery in minutes (note non-linear
scale). The OVAR chair is shown as a
small inset.(B) Values for individual
participants for MSSQ percentile
(y axis) before (x axis point 1) and
after (x axis point 2) the onset of
vestibular symptoms for VN, BVF and
VM groups. The three groups are
displayed adjacent and on the same
y axis scale for ease of comparison.
Note that the majority of individuals in
the BVF group experience a reduction
in motion sickness susceptibility, while
by contrast the majority of the VM
group experience an increase in
motion sickness susceptibility. The VN
group picture is mixed. BVF, bilateral
vestibular failure; M, migraine; MSSQ,
Motion Sickness Susceptibility
Questionnaire; OVAR, off-vertical axis
rotation; SR, Sickness Rating; VM,
vestibular migraine; VN, vestibular
neuritis
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brought back to rest and earth vertical
over 30 s.
At every minute during rotation, partici-
pants rated nausea on a scale from: 1=no
symptoms, 2=initial symptoms but no
nausea, 3=mild nausea, 4=moderate
nausea. Rotation continued until partici-
pants Sickness Rating (SR) of 4 or to a
maximum of 20 min. To quantify recovery,
SRs were also obtained at 1, 2, 3, 4, 5, 10,
15, 20 and 30 min after motion end point.
Individual motion sickness susceptibility
was reported before rotation using the
Motion Sickness Susceptibility
Questionnaire, short form (MSSQ-Short).2
Brieﬂy, participants were asked to report
retrospectively the frequency of experien-
cing nausea on various forms of transport/
motion. Those in the VN, BVF and VM
groups also scored themselves after the
onset of vestibular disease.
Figure 1A shows the mean Sickness
Rating scores against time during rotation
for all ﬁve groups (p<0.001, analysis of
variance). Participants who did not reach
SR 4 were allocated values of 20 min for
analysis. All patients with BVF tolerated
motion to 20 min with no scores of SR 4
reported, and 38% patients with BVF
remained at SR 1 (no nausea) for the
whole test duration with no participant in
any other group demonstrating this effect.
Comparing the time to recovery (no
nausea) after rotation ceased, there is a sig-
niﬁcant difference between groups
(p<0.001), attributable to the difference
between VM/M and the other groups.
There was no relationship between side of
lesion in the VN group and time to SR 4
(p=0.21, Kruskal-Wallis), and no correlation
between MSSQ and canal paresis (p=0.31).
Mean and IQR for MSSQ were
(control (10.0, 8.2); VN (13.7, 15.4);
BVF (8.5, 5,9); VM (20.7, 13.7) and M
(30.1, 15.3) groups; p=0.004). Of the
patients with BVF, 13% developed an
increased MSSQ score after the onset of
their vestibular disorder, and 50%
reported decreases. For the VN group, the
corresponding result was 42% increased
and 42% decreased; for VM 75%
increased and 17% decreased.
Intraindividual changes are depicted in
ﬁgure 1B. There was a signiﬁcant differ-
ence between groups (p=0.009) in sus-
ceptibility after illness onset, due to the
patients with VM and BVF showing
oppositely directed trends.
Our study, using validated experimental
and questionnaire paradigms, conﬁrms
that individuals with BVF report and dem-
onstrate low levels of motion sickness sus-
ceptibility that were not present prior to
disease acquisition.
Although all BVF individuals could
withstand the 20 min rotation, some were
not completely immune, perhaps because
of residual vestibular function. Some
degree of otolith function could still be
present since caloric and rotational tests
primarily assess horizontal semicircular
canal function. It is also known that visual
stimuli can provoke symptoms,4 and since
the experiment took place in the light,
this may be an alternative explanation.
Seasickness commonly has a negative
impact on leisure and tourism activities
such as sailing and cruise travel. Ability to
identify positive aspects of a condition can
predict outcome in chronic conditions. We
therefore recommend that patients with
BVF be advised of this beneﬁcial aspect of
their condition. Those with VN, a unilateral
lesion, do not share this beneﬁcial effect.
There is an overall increase in motion
sickness susceptibility of patients with VM
but this is not different from migraine. This
contrasts with ﬁndings of previous studies
that have shown higher susceptibility scores
in questionnaires in VM than migraine in
general.5 Unlike any previous study, the
questionnaire data from our study are sup-
ported by the experimental data. Some indi-
viduals with VM reported reductions in
susceptibility, suggesting some heterogeneity
in the underlying pathomechanism, which
could also explain some observed differences
between ours and previous studies.
In conclusion, BVF reduces motion
sickness susceptibility, and this can be
regarded as a beneﬁcial effect of this dis-
order, but a unilateral lesion is insufﬁcient
to trigger such a reduction. VM and
migraine similarly enhance motion sick-
ness susceptibility proﬁles.
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